TY - JOUR
T1 - Subcutaneous fat necrosis and hypercalcemia following therapeutic hypothermia - A patient report and review of the literature
AU - Zifman, Eyal
AU - Mouler, Marie
AU - Eliakim, Alon
AU - Nemet, Dan
AU - Pomeranz, Avishalom
PY - 2010/11
Y1 - 2010/11
N2 - Subcutaneous fat necrosis (SCFN) of the newborn is an uncommon dermatologic disorder characterized by firm, palpable subcutaneous nodules or plaques with or without erythema. Despite its benign course, SCFN may become complicated by extracutaneous manifestations. Hypercalcemia is considered a rare complication, but it is potentially fatal if unrecognized. During the last several years therapeutic hypothermia (TH) became an essential new therapeutic modality for severe neonatal asphyxia. We report a neonate who presented with SCFN and hypercalcemia following hypothermia therapy for hypoxic ischemic encephalopathy (HIE) and provide a review of the contemporary literature on the topic. We believe that this is important since the use of TH is rapidly increasing, and therefore, the possible side effects including SCFN and hypercalcemia may also become more prevalent. This prompts the need for awareness by treating physicians for this complication.
AB - Subcutaneous fat necrosis (SCFN) of the newborn is an uncommon dermatologic disorder characterized by firm, palpable subcutaneous nodules or plaques with or without erythema. Despite its benign course, SCFN may become complicated by extracutaneous manifestations. Hypercalcemia is considered a rare complication, but it is potentially fatal if unrecognized. During the last several years therapeutic hypothermia (TH) became an essential new therapeutic modality for severe neonatal asphyxia. We report a neonate who presented with SCFN and hypercalcemia following hypothermia therapy for hypoxic ischemic encephalopathy (HIE) and provide a review of the contemporary literature on the topic. We believe that this is important since the use of TH is rapidly increasing, and therefore, the possible side effects including SCFN and hypercalcemia may also become more prevalent. This prompts the need for awareness by treating physicians for this complication.
UR - http://www.scopus.com/inward/record.url?scp=78650566578&partnerID=8YFLogxK
U2 - 10.1515/jpem.2010.186
DO - 10.1515/jpem.2010.186
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:78650566578
SN - 0334-018X
VL - 23
SP - 1185
EP - 1188
JO - Journal of Pediatric Endocrinology and Metabolism
JF - Journal of Pediatric Endocrinology and Metabolism
IS - 11
ER -